Skip to content

Non-invasive Device for the Screening and Diagnosis of Sleep Apnea Syndrome

Non-invasive Device for the Screening and Diagnosis of Sleep Apnea Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03632382
Acronym
Episas
Enrollment
280
Registered
2018-08-15
Start date
2018-07-27
Completion date
2020-09-08
Last updated
2021-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Sleep apnea diagnosis, 3D acquisition

Brief summary

This prospective study aims to establish and evaluate a predictive model to diagnose OSA with maxillofacial characteristics 3D acquisition.

Detailed description

Polysomnography is the gold-standard for obstructive sleep apnea (OSA) diagnosis. However, OSA is still undiagnosed. Maxillofacial profile can influence OSA severity. Morphological characteristics can be identified but are not enough measurable and analysable by physicians. 3D acquisition of maxillofacial characteristics with a user-friendly tool, quick and low-priced could be used to obtain a predictive model as an OSA risk indicator. Thus, the aim of this study is to establish and evaluate a predictive model to diagnose OSA with maxillofacial characteristics 3D acquisition.

Interventions

DIAGNOSTIC_TEST3D acquisition of maxillofacial characteristics

A 3D acquisition of maxillofacial characteristics will be performed for each patient in order to validate a predictive model comparable to data obtained by polysomnography

Sponsors

SATT Linksium GRENOBLE
CollaboratorUNKNOWN
ARTEHIS
CollaboratorUNKNOWN
ARCTIC
CollaboratorUNKNOWN
University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Prospective

Eligibility

Sex/Gender
MALE
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI \< 35 kg/m² * caucasian men * patients from the sleep laboratory (CHU Grenoble Alpes) admitted for a polysomnography * Patient who has given free and informed consent in writing

Exclusion criteria

* history of maxillofacial surgery * dental malocclusion * patient involved in another clinical research study * patient not affiliated with social security * patient deprived of liberty or hospitalized without consent

Design outcomes

Primary

MeasureTime frameDescription
Establish and evaluate a predictive model for OSA diagnosis by 3D acquisition of characteristics maxillofacial1 measure at inclusionapnea hypopnea index will be measured by polysomnography for each patient and compared to a predictive model establish from body mass index and 3D acquisition (cricomental distance...)

Secondary

MeasureTime frameDescription
Sensitivity study from different stages of OSA severity1 measure at inclusionOSA severity stages will be apnea hypopnea index \<5, \<10, \<15
Compare diagnosis performances of predictive model and Berlin or NoSAS questionnaires1 measure at inclusionCorrelation between the Berlin or NoSAS score and the predictive model results
Evaluate performances of the combination (Berlin questionnaire + predictive model) to estimate the OSA risk1 measure at inclusionCalculate the sensitivity, specificity, predictive positive value and predictive negative value of the combination

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026